Le Lézard
Classified in: Transportation, Covid-19 virus

Doppler's proven track record eliminates the risks of at-home product delivery for Dealer's and OEMs


LOS ANGELES, March 30, 2020 /PRNewswire/ -- The auto industry has been on a path of transformation for several years with varying degrees of success. It is well down the digital transformation path with some early successes, although challenges remain. Now, the COVID-19 pandemic has accelerated the need for change in every aspect of dealership operations in a matter of weeks. While the pandemic will eventually pass, we need to get ready for a "new normal", the likes of which we have never seen before.

Many dealers, OEM's and providers have rushed out various ad-hoc forms of at-home services in an effort to address an immediate need.  The belief that anything is better than nothing may haunt them due to unintended consequences. Handling customers at home, on their terms, is a completely different dynamic from activities in a dealership. As Doppler has learned during the last 2 years, without specific experience in handling customers on their turf, there is the potential to do more damage to the brand and the dealership's reputation than good. Doppler answers these challenges in several ways, including removing the liability risk of accidental COVID-19 exposure now assumed by OEMs and dealers doing "home deliveries."

In this "new normal," Doppler has found the consumer mindset is all about trust, operational excellence and avoiding risks. OEMs and dealers should have the same mindset.

Doppler was developed and battle tested over the last 2 years to provide the highest quality of at-home product and brand experience  in the industry. We have dedicated staff, trained specifically to deliver an in home, pressure free branded experience that consumers trust.  Consumers as well as dealers love Doppler and give it an extraordinary 99% Net Promoter Score.

Doppler's technology platform is world class with a dispatch and delivery experience rivalling Uber or Lyft. From the outset, Doppler has focused on safety and protection. The entire operation follows all CDC guidelines in this era of social distancing. Importantly, we eliminate risk and handle all liability thus protecting both the OEM and the dealer.

Veteran auto industry executive, retailer and AVC Capital advisor Jim Press said, "Speed is important, but OEMs and dealers should pause long enough to seek the best possible, risk free and scalable solution in the market. Doppler has the talent and most experience to do it best and protect the brand, OEMs, dealers and customers."

Doppler has been successfully used by both luxury and mass market brands at tier 1, 2 and 3. It is easily white-labeled to  worked within a brand's existing channels like none other. Doppler at-home product and brand experience will be a critical factor in the industry successfully adapting to the "new normal."

About Doppler Automotive

Doppler Automotive is a customer-first shopping platform available to OEMs and dealers that empowers the customer by delivering anywhere anytime product and brand experiences. For more information go to: www.dopplerdrives.com 

SOURCE AVC Capital Group


These press releases may also interest you

at 12:50
Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired QuidelOrtho Corporation ("QuidelOrtho"...

at 11:40
The "Global Needle Coke Market: Focus on Application, Type, Grade, End Use, and Country-Level Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global needle coke market was valued at $3.05...

at 11:15
Expomed Eurasia, the most important medical exhibition between Europe and Asia, is ready to house more than a hundred companies, to discover new technological trends and the most innovative products which are going to change deeply the health market....

at 11:15
Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product. Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialization of NIOPEG® (a...

at 09:35
Two large multi-state studies uncovered a highly effective way to improve antibiotic selection for patients hospitalized with pneumonia or urinary tract infections (UTI), enabling better antibiotic stewardship in hospitals, according to research...

at 09:25
The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth analyses of: the scope of telehealth usage in the U.S., telehealth user demographics, pros and...



News published on and distributed by: